• Issue

    HIV Medicine: Volume 25, Issue 10

    1099-1179
    October 2024
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 1099-1100
  • First Published: 06 October 2024

ORIGINAL ARTICLE

Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy

Vincenzo Malagnino,  Alessandro Cozzi-Lepri,  Valentina Svicher,  Enrico Girardi,  Carlo Federico Perno,  Annalisa Saracino,  Gianluca Cuomo,  Stefano Rusconi,  Massimo Puoti,  Antonella D'Arminio Monforte,  Massimo Andreoni,  Loredana Sarmati,  ICONA Foundation Study Group , 
  • Pages: 1101-1111
  • First Published: 04 June 2024
Open Access

Impact of hormonal therapy on HIV-1 immune markers in cis women and gender minorities

Chloé Pasin,  David Garcia Nuñez,  Katharina Kusejko,  Anna Hachfeld,  Hélène Buvelot,  Matthias Cavassini,  Lauro Damonti,  Christoph Fux,  Begoña Martinez de Tejada,  Julia Notter,  Alexandra Trkola,  Huldrych F. Günthard,  Karoline Aebi-Popp,  Roger D. Kouyos,  Irene A. Abela,  the Swiss HIV Cohort Study , 
  • Pages: 1112-1124
  • First Published: 03 June 2024
Open Access

Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI-net)

Kyle Ring,  Melanie Smuk,  Moses Shongwe,  Leroy Okonta,  Nicola E. Mackie,  Sara Ayres,  Tristan J. Barber,  Jane Akodu,  Filippo Ferro,  Daniella Chilton,  Eliot Hurn,  Bhavna Halai,  Will Barchi,  Asim Ali,  Sandra Darko,  Gemma White,  Emily Clarke,  Fiona Clark,  Bazga Ali,  Joseph Arumainayagam,  Gaynor Quinn,  Marta Boffito,  Ruth Byrne,  Nadia Naous,  Suki Leung,  Athavan Umaipalan,  Brian Thornton,  David Bayliss,  Catherine McLoughlin,  Jonathan Foster,  Laura Waters,  Chloe Orkin, 
  • Pages: 1125-1134
  • First Published: 10 June 2024
Open Access

HCV-HIV co-infection in people who inject drugs: Barriers to treatment and cure of HCV infection in the era of DAAs, a prospective study in Athens, Greece

Dimitris Basoulis,  Elpida Mastrogianni,  Irene Eliadi,  Martha Papadopoulou,  Mina Psichogiou, 
  • Pages: 1135-1144
  • First Published: 20 June 2024

Prevalence of anal high-risk human papillomavirus (HR-HPV) types in people living with HIV and a history of cancer

Salim A. Barquet-Muñoz,  Roxana A. López-Morales,  Elizabeth A. Stier,  Emmanuel Mejorada-Pulido,  Diego Solís-Ramírez,  Naomi Jay,  Paulina Moctezuma,  Mariel Morales-Aguirre,  Alejandro García-Carrancá,  Rocío Méndez-Martínez,  Alexandra Martin-Onraët,  Delia Pérez-Montiel,  María José Mendoza-Palacios,  Patricia Volkow, 
  • Pages: 1145-1153
  • First Published: 20 June 2024

Clinicopathological concordance of mucocutaneous manifestations in people living with HIV: A cross-sectional study

Dalit Zajdman-Faitelson,  Miren Lorea Cárdenas-Hernández,  Simón Guzmán-Bucio,  Antonio Camiro-Zuñiga,  Maria Elisa Vega Memije, 
  • Pages: 1154-1161
  • First Published: 08 July 2024

SHORT COMMUNICATION

Clinically recognized sleep disorders in people living with HIV

Jennifer O. Lam,  Craig E. Hou,  Stacey Alexeeff,  Tory Levine,  Varada Sarovar,  Alexandra N. Lea,  Verena E. Metz,  Michael A. Horberg,  Derek D. Satre,  Michael J. Silverberg, 
  • Pages: 1162-1168
  • First Published: 18 June 2024
Open Access

The HepHIV 2023 Madrid conference: A call to action for political leadership in reaching the sustainable development goals on earlier testing and linkage to care for HIV, viral hepatitis, and sexually transmitted infections

Daniel Simões,  Dorthe Raben,  Alejandro Bertó Moran,  Arkaitz Imaz,  Annemarie Rinder Stengaard,  Anne Raahauge,  Ann K. Sullivan,  Elena Vaughan,  Johanna Brännström,  Irith De Baetselier,  Tom Platteau,  Jordi Casabona,  Julia Del Amo, on behalf of the 2023 HepHIV Conference Organising Committee and the EuroTEST Steering Committee , 
  • Pages: 1169-1176
  • First Published: 24 June 2024

LETTER TO THE EDITOR

Commentary on ‘Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI-net)’

Sanjit Sah,  Amogh Verma,  Quazi Syed Zahiruddin,  Sarvesh Rustagi, 
  • Pages: 1177-1178
  • First Published: 01 August 2024

CORRECTION

Free Access

Correction to “Severe haematologic toxicity is rare in high risk HIV-exposed infants receiving combination neonatal prophylaxis”

  • Page: 1179
  • First Published: 11 September 2024